Nasdaq:US$15.74 (+0.38) | HKEX:HK$24.22 (-0.50) | AIM:£2.24 (+0.04)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 27 Sep 2015

ESMO 2015: Phase II trial of fruquintinib in metastatic colorectal cancer

1 items
View PDF